Appropriate premedication risk reduction during adrenal ablation.
Sudheendra
Deepak
D
Wood
Bradford J
BJ
D000310:Adrenal Gland Neoplasms / Q000000981:diagnostic imaging / Q000601:surgery*; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003452:Cryosurgery / Q000009:adverse effects*; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006974:Hypertension, Malignant / Q000209:etiology / Q000517:prevention & control*; D010643:Phenoxybenzamine / Q000627:therapeutic use; D015641:Radiography, Interventional; D018570:Risk Assessment; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors; D019805:alpha-Methyltyrosine / Q000494:pharmacology / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents; D004791:Enzyme Inhibitors; D010643:Phenoxybenzamine; D019805:alpha-Methyltyrosine; D014446:Tyrosine 3-Monooxygenase